The Scientist

» misconduct

Most Recent

image: Patent Granted for Fraudulent Science

Patent Granted for Fraudulent Science

By | February 17, 2014

The US Patent and Trademark Office has awarded patent protection to refuted discoveries on human stem cells.  

2 Comments

image: Opinion: Reducing Whistleblower Risk

Opinion: Reducing Whistleblower Risk

By | February 11, 2014

It takes significant time and money for a scientist to defend his or her accusation of research misconduct.

5 Comments

image: More Retractions for Fallen Scientist

More Retractions for Fallen Scientist

By | February 7, 2014

Molecular and Cellular Biology pulls five papers from endocrinologist Shigeaki Kato.

1 Comment

image: Unauthorized HIV Trial Leader Fined

Unauthorized HIV Trial Leader Fined

By | February 3, 2014

A Spanish researcher faces a penalty after conducting a study for which he never obtained proper approvals or insurance.

0 Comments

image: Scandalous GSK Paper Retracted

Scandalous GSK Paper Retracted

By | December 10, 2013

The publication at the center of a June controversy for drugmaker GlaxoSmithKline is finally pulled from the literature.

4 Comments

image: What to Do About “Clare Francis”

What to Do About “Clare Francis”

By | September 14, 2013

Anonymous tipsters who allege scientific misconduct can make journal editors squeamish. But should a whistleblower's identity matter?

7 Comments

image: More Retractions for Tokyo Scientist?

More Retractions for Tokyo Scientist?

By | July 26, 2013

A university panel has detected irregularities in 43 papers by Shigeaki Kato.

0 Comments

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Editor Quits After Fraud Allegations

Editor Quits After Fraud Allegations

By | July 10, 2013

Dmitry Kuznetsov, former chief editor of two science journals, denies any wrongdoing, but agrees to leave his posts after The Scientist reported on numerous accusations of misconduct.

4 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Rainin Instrument
Rainin Instrument
Advertisement
Life Technologies